Little Green Pharma Ltd (LGP) - Total Assets
Based on the latest financial reports, Little Green Pharma Ltd (LGP) holds total assets worth AU$97.60 Million AUD (≈ $69.06 Million USD) as of September 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. See LGP net asset value for net asset value and shareholders' equity analysis.
Little Green Pharma Ltd - Total Assets Trend (2017–2025)
This chart illustrates how Little Green Pharma Ltd's total assets have evolved over time, based on quarterly financial data.
Little Green Pharma Ltd - Asset Composition Analysis
Current Asset Composition (June 2025)
Little Green Pharma Ltd's total assets of AU$97.60 Million consist of 23.6% current assets and 76.4% non-current assets.
| Asset Category | Amount (AUD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | AU$2.38 Million | 2.5% |
| Accounts Receivable | AU$3.96 Million | 4.1% |
| Inventory | AU$13.83 Million | 14.4% |
| Property, Plant & Equipment | AU$60.30 Million | 62.7% |
| Intangible Assets | AU$3.36 Million | 3.5% |
| Goodwill | AU$856.00K | 0.9% |
Asset Composition Trend (2017–2025)
This chart illustrates how Little Green Pharma Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see Little Green Pharma Ltd market cap and net worth.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Little Green Pharma Ltd's current assets represent 23.6% of total assets in 2025, a decrease from 84.6% in 2017.
- Cash Position: Cash and equivalents constituted 2.5% of total assets in 2025, down from 75.0% in 2017.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 3.0% of total assets, an increase from 2.0% in 2017.
- Asset Diversification: The largest asset category is property, plant & equipment at 62.7% of total assets.
Little Green Pharma Ltd Competitors by Total Assets
Key competitors of Little Green Pharma Ltd based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Jiangsu Hengrui Medicine Co Ltd
SHG:600276
|
China | CN¥68.33 Billion |
|
GALDERMA GROUP AG
NYSE:GALDY
|
USA | $13.39 Billion |
|
Swedish Orphan Biovitrum AB (publ)
ST:SOBI
|
Sweden | Skr67.43 Billion |
|
Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt
F:RIG2
|
Germany | €1.60 Trillion |
|
Regencell Bioscience Holdings Ltd
NASDAQ:RGC
|
USA | $5.76 Million |
|
Shan Dong Dong-E E-Jiao Co Ltd
SHE:000423
|
China | CN¥12.75 Billion |
|
Beijing New Oriental Star Petrochemical Engineering Co Ltd
SHE:002755
|
China | CN¥4.44 Billion |
|
Henan Newland Pharmaceutical Co. Ltd. A
SHE:301277
|
China | CN¥1.77 Billion |
Little Green Pharma Ltd - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 3.19 | 2.64 | 2.37 |
| Quick Ratio | 0.87 | 1.01 | 1.86 |
| Cash Ratio | 0.30 | 0.61 | 0.00 |
| Working Capital | AU$16.63 Million | AU$13.01 Million | AU$909.55K |
Little Green Pharma Ltd - Advanced Valuation Insights
This section examines the relationship between Little Green Pharma Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 0.44 |
| Latest Market Cap to Assets Ratio | 0.22 |
| Asset Growth Rate (YoY) | 11.3% |
| Total Assets | AU$96.12 Million |
| Market Capitalization | $21.63 Million USD |
Valuation Analysis
Below Book Valuation: The market values Little Green Pharma Ltd's assets below their book value (0.22x), which may indicate investor concerns about asset quality or future growth.
Rapid Asset Growth: Little Green Pharma Ltd's assets grew by 11.3% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for Little Green Pharma Ltd (2017–2025)
The table below shows the annual total assets of Little Green Pharma Ltd from 2017 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-06-30 | AU$96.12 Million ≈ $68.01 Million |
+11.28% |
| 2024-06-30 | AU$86.38 Million ≈ $61.12 Million |
-12.41% |
| 2023-06-30 | AU$98.62 Million ≈ $69.78 Million |
+2.79% |
| 2022-06-30 | AU$95.95 Million ≈ $67.89 Million |
-13.56% |
| 2021-06-30 | AU$110.99 Million ≈ $78.53 Million |
+576.58% |
| 2020-06-30 | AU$16.40 Million ≈ $11.61 Million |
+5.39% |
| 2019-06-30 | AU$15.57 Million ≈ $11.01 Million |
+287.07% |
| 2018-06-30 | AU$4.02 Million ≈ $2.85 Million |
+315.13% |
| 2017-06-30 | AU$968.73K ≈ $685.44K |
-- |
About Little Green Pharma Ltd
Little Green Pharma Ltd engages in the cultivation, production, and distribution of medicinal cannabis products in Australia and internationally. The company offers dried cannabis flower medicines and cannabis oils. Little Green Pharma Ltd was incorporated in 2016 and is based in West Perth, Australia.